The diagnostic gray zone between Burkitt lymphoma and diffuse large B-cell lymphoma is also a gray zone of the mutational spectrum

Leukemia. 2015 Aug;29(8):1789-91. doi: 10.1038/leu.2015.34. Epub 2015 Feb 12.

Authors

S Momose¹, S Weißbach¹, J Pischimarov¹, T Nedeva¹, E Bach², M Rudelius¹, E Geissinger¹, A M Staiger³, G Ott³, A Rosenwald¹

Affiliations

¹ 1] Institute of Pathology, University of Würzburg, Würzburg, Germany [2] Comprehensive Cancer Center Mainfranken (CCC MF), Würzburg, Germany.
² Department of Human Genetics, University of Würzburg, Würzburg, Germany.
³ Department of Clinical Pathology, Robert-Bosch-Krankenhaus and Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany.

PMID: 25673238
DOI: 10.1038/leu.2015.34

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Biomarkers, Tumor / genetics*
Burkitt Lymphoma / diagnosis*
Burkitt Lymphoma / genetics*
Humans
In Situ Hybridization, Fluorescence
Lymphoma, Large B-Cell, Diffuse / diagnosis*
Lymphoma, Large B-Cell, Diffuse / genetics*
Mutation / genetics*
Prognosis

Substances

Biomarkers, Tumor